Two doses of the human attenuated rotavirus vaccine RIX4414 (Rotarix) show heterotypic protection in Latin America and Europe. Perez-Schael I, Linhares AC, & Vesikari T In Washington D.C., 2005.
bibtex   
@inproceedings{perez-schael_i_two_2005,
	address = {Washington D.C.},
	title = {Two doses of the human attenuated rotavirus vaccine {RIX4414} ({Rotarix}) show heterotypic protection in {Latin} {America} and {Europe}},
	author = {{Perez-Schael I} and {Linhares AC} and {Vesikari T}},
	year = {2005},
}

Downloads: 0